摘要
从1981年1月至1991年12月，我们共收治可手术见期乳腺癌61例，其中术前化疗36例，非术前化疗25例。术前化疗组中，经尺动脉插管给药19例，静脉给药17例，有效率分别为73．7％和76．5％（P>0．05），5年生存率分别为68．4％和70．6％（P>0．05），总有效率和5年生率率分别为75．0％和69．4％。5年生存率明显高于非术前化疗组的36．0％（P<0．05）。结果表明：术前化疗对改善可手术Ⅲ期乳腺癌的预后有其重要的意义。
Sixty-one patients with stage Ⅲ operable breast cancer were treated from Jan. 1981to Dec, 1991. All patients were divided into preoperative chemotherapy group (36cases ) and control group (25 cases). In the group of preoperative chemotherapy, nineteen patients were treated by trans-catheter intraarterial infusion, and seventeen patients were treated by venoclysis. The effective rate to preoperative chemotherapy intwo groups was 73. 7 % and 76. 5 % (P>0. 05),respectively. The 5-year survival rate was68. 4% and 70. 6% (P>0. 05),respectively. Total effective rate and 5-year survival rateof the preoperative chemotherapy were 75. 0% and 69. 4%, respectively. The 5-yearsurvival rate was higher than that of control group (36. 0%,P<0. 05). The results indicate that the preoperative chemotherapy on the prognosis of stage Ⅲ operable breastcancer has an important effect.
出处
《肿瘤防治研究》
CAS
CSCD
北大核心
1998年第4期291-293,共3页
Cancer Research on Prevention and Treatment
关键词
乳腺癌
术前化疗
生存率
外科手术
Breast cancer
Preoperative chemotherapy Five-year survival rate
Effective rate
Effective rate
